Jane Craig

2.1k total citations · 1 hit paper
23 papers, 1.7k citations indexed

About

Jane Craig is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Jane Craig has authored 23 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Infectious Diseases and 8 papers in Virology. Recurrent topics in Jane Craig's work include HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (8 papers) and Virus-based gene therapy research (2 papers). Jane Craig is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (8 papers) and Virus-based gene therapy research (2 papers). Jane Craig collaborates with scholars based in Canada, United Kingdom and United States. Jane Craig's co-authors include I. B. R. Duncan, John Mills, Noel A. Roberts, Michael W. McBurney, N. A. Roberts, Antonin Kröhn, Anne V. Broadhurst, K. E. B. PARKES, Gareth J. Thomas and Debra L. Taylor and has published in prestigious journals such as Science, Journal of Neuroscience and The Journal of Cell Biology.

In The Last Decade

Jane Craig

22 papers receiving 1.6k citations

Hit Papers

Rational Design of Peptide-Based HIV Proteinase Inhibitors 1990 2026 2002 2014 1990 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Rational Design of Peptide-Based HIV Proteinase Inhibitors
    1990 726 citations Noel A. Roberts, Joseph A. Martin et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane Craig Canada 16 965 872 721 239 148 23 1.7k
Mary Jane Potash United States 26 523 0.5× 1.3k 1.5× 693 1.0× 66 0.3× 340 2.3× 62 2.1k
K De Vreese Belgium 18 570 0.6× 708 0.8× 379 0.5× 116 0.5× 316 2.1× 22 1.6k
Paolo Ingallinella Italy 17 427 0.4× 329 0.4× 527 0.7× 53 0.2× 236 1.6× 27 1.2k
Elizabeth D. Anton United States 14 442 0.5× 444 0.5× 1.1k 1.5× 32 0.1× 191 1.3× 21 1.7k
Katherine M. Brendza United States 19 374 0.4× 268 0.3× 714 1.0× 89 0.4× 208 1.4× 24 1.3k
Henry J. George United States 13 266 0.3× 308 0.4× 455 0.6× 28 0.1× 99 0.7× 19 842
Mark Andrake United States 21 455 0.5× 370 0.4× 1.5k 2.1× 35 0.1× 212 1.4× 55 2.1k
Dawn L. Hall United States 14 279 0.3× 125 0.1× 508 0.7× 105 0.4× 234 1.6× 16 930
Katrien Princen Belgium 16 233 0.2× 424 0.5× 521 0.7× 131 0.5× 78 0.5× 28 1.4k
Katrin Kaehlcke United States 13 180 0.2× 390 0.4× 810 1.1× 20 0.1× 365 2.5× 13 1.5k

Countries citing papers authored by Jane Craig

Since Specialization
Citations

This map shows the geographic impact of Jane Craig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Craig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Craig more than expected).

Fields of papers citing papers by Jane Craig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Craig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Craig. The network helps show where Jane Craig may publish in the future.

Co-authorship network of co-authors of Jane Craig

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Craig. A scholar is included among the top collaborators of Jane Craig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Craig. Jane Craig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roberts, Noel A., et al.. (1998). Resistance and cross-resistance with saquinavir and other HIV protease inhibitors. AIDS. 12(5). 453–460. 57 indexed citations
2.
Staines, William A., et al.. (1996). Retinoic acid treated P19 embryonal carcinoma cells differentiate into oligodendrocytes capable of myelination. Neuroscience. 71(3). 845–853. 35 indexed citations
3.
Slack, Ruth S., Jane Craig, Sílvia Lima Costa, & M W McBurney. (1995). Adenovirus 5 E1A induced differentiation of P19 embryonal carcinoma cells requires binding to p300.. PubMed. 10(1). 19–25. 9 indexed citations
4.
Jacobsen, Helmut, et al.. (1995). Characterization of human immunodeficiency virus type 1 mutantswith decreased sensitivity to proteinase inhibitor Ro 31-8959. Virology. 206(1). 527–534. 173 indexed citations
5.
McBurney, Michael W., et al.. (1994). Unstable integration of transfected DNAs into embryonal carcinoma cells. Somatic Cell and Molecular Genetics. 20(6). 529–540. 13 indexed citations
6.
Craig, Jane, Lynne Whittaker, I. B. R. Duncan, & N. A. Roberts. (1994). In vitroanti-HIV and Cytotoxicological Evaluation of the Triple Combination: AZT and ddC with HIV Proteinase Inhibitor Saquinavir (Ro 31-8959). Antiviral chemistry & chemotherapy. 5(6). 380–386. 21 indexed citations
7.
Craig, Jane, Lynne Whittaker, I. B. R. Duncan, & N. A. Roberts. (1993). In vitroResistance to an Inhibitor of HIV Proteinase (Ro 31-8959) Relative to Inhibitors of Reverse Transcriptase (AZT and TIBO). Antiviral chemistry & chemotherapy. 4(6). 335–339. 27 indexed citations
8.
Craig, Jane, I. B. R. Duncan, D. J. Hockley, et al.. (1991). Antiviral properties of Ro 31-8959, an inhibitor of human immunodeficiency virus (HIV) proteinase. Antiviral Research. 16(4). 295–305. 151 indexed citations
9.
Craig, Jane, C. Grief, John Mills, et al.. (1991). Effects of a Specific Inhibitor of HIV Proteinase (Ro 31-8959) on Virus Maturation in a Chronically Infected Promonocytic Cell Line (U1). Antiviral chemistry & chemotherapy. 2(3). 181–186. 23 indexed citations
10.
Rudnicki, Michael A., Nancy Sawtell, Kenneth R. Reuhl, et al.. (1990). Smooth muscle actin expression during P19 embryonal carcinoma differentiation in cell culture. Journal of Cellular Physiology. 142(1). 89–98. 49 indexed citations
11.
Roberts, Noel A., Joseph A. Martin, Derek Kinchington, et al.. (1990). Rational Design of Peptide-Based HIV Proteinase Inhibitors. Science. 248(4953). 358–361. 726 indexed citations breakdown →
12.
St‐Arnaud, René, et al.. (1989). The int-1 proto-oncogene is transcriptionally activated during neuroectodermal differentiation of P19 mouse embryonal carcinoma cells.. PubMed. 4(9). 1077–80. 31 indexed citations
13.
Craig, Jane, Margaret Haire, & J. D. Merrett. (1988). T-cell-mediated suppression of Epstein-Barr virus-induced B lymphocyte activation in multiple sclerosis. Clinical Immunology and Immunopathology. 48(3). 253–260. 15 indexed citations
14.
Ruben, Martha, et al.. (1988). Expression of the human cardiac actin gene in differentiating rat skeletal myoblasts. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 950(3). 374–384.
15.
McBurney, M W, et al.. (1988). Differentiation and maturation of embryonal carcinoma-derived neurons in cell culture. Journal of Neuroscience. 8(3). 1063–1073. 180 indexed citations
16.
Bell, John C., et al.. (1987). Restricted Replication of Herpes Simplex Virus Type 1 in Murine Embryonal Carcinoma Cells. Journal of General Virology. 68(2). 555–568. 2 indexed citations
17.
Smith, Steven C., Kenneth R. Reuhl, Jane Craig, & Michael W. McBurney. (1987). The role of aggregation in embryonal carcinoma cell differentiation. Journal of Cellular Physiology. 131(1). 74–84. 54 indexed citations
18.
Sun, Junjie, et al.. (1985). Cell-cell interaction can influence drug-induced differentiation of murine embryonal carcinoma cells. Developmental Biology. 109(1). 25–31. 15 indexed citations
19.
Craig, Jane, et al.. (1984). DNA methylation in differentiating mouse teratocarcinoma and erythroleukemia cells. Canadian Journal of Biochemistry and Cell Biology. 62(7). 584–591. 6 indexed citations
20.
McBurney, Michael W., et al.. (1981). Expression of globin genes in teratocarcinoma-Friend cell hybrids. Experimental Cell Research. 131(2). 277–282. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary Jane Potash Breakdown of academic impact, for papers by K De Vreese Breakdown of academic impact, for papers by Paolo Ingallinella Breakdown of academic impact, for papers by Elizabeth D. Anton Breakdown of academic impact, for papers by Katherine M. Brendza Breakdown of academic impact, for papers by Henry J. George Breakdown of academic impact, for papers by Mark Andrake Breakdown of academic impact, for papers by Dawn L. Hall Breakdown of academic impact, for papers by Katrien Princen Breakdown of academic impact, for papers by Katrin Kaehlcke
Rankless by CCL
2026